Molecular understanding of the circadian clock is opening new therapeutic frontiers for several diseases—including sleep and metabolic disorders, inflammatory diseases, and cancer—through pharmacological targeting of circadian clock components [23]. This evidence concerns the gene CLOCK and cancer.